Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials

Published:2018-12-17 Issue:7 Volume:40 Page:607-617
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Mahmoud Ahmed N¹,Gad Mohamed M²,Elgendy Akram Y¹,Elgendy Islam Y¹,Bavry Anthony A¹³

Affiliation:

1. Division of Cardiovascular Medicine, Department of Medicine, University of Florida, 1600 SW Archer Road, Gainesville, FL, USA

2. Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, USA

3. North Florida/South Georgia Veterans Health System, Malcom Randall Veterans Administration Medical Center, Medical Service, Cardiology Section (111D), 1601 SW Archer Road, Gainesville, FL, USA

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/40/7/607/27775904/ehy813.pdf

Reference30 articles.

1. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR);Piepoli;Eur Heart J,2016

2. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement;Bibbins-Domingo;Ann Intern Med,2016

3. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association;Fox;Circulation,2015

4. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials;Baigent;Lancet,2009

5. Recent trends in the prevalence of low-dose aspirin use for primary and secondary prevention of cardiovascular disease in the United States, 2012-2015;Stuntz;Prev Med Rep,2017

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acetylsalicylic acid in primary prevention: a review;Italian Journal of Medicine;2024-08-29

2. Advancements in risk stratification and management strategies in primary cardiovascular prevention;Atherosclerosis;2024-08

3. Evaluating Aspirin’s Efficacy for Primary Prevention in Cardiovascular and Cerebrovascular Disease: Insights from a Nationwide Cohort Study;Clinics and Practice;2024-07-15

4. Characteristics and efficacy of traditional Chinese medicine in the therapeutic strategy of chronic coronary syndrome: A systematic review and meta-analysis;Phytomedicine;2024-07

5. Carotid Ultrasound‐Based Plaque Score for the Allocation of Aspirin for the Primary Prevention of Cardiovascular Disease Events: The Multi‐Ethnic Study of Atherosclerosis and the Atherosclerosis Risk in Communities Study;Journal of the American Heart Association;2024-06-18